Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of …

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

NOX66 and Palliative Radiotherapy in Patients with Late-Stage Prostate Cancer

The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of …

CONDITION: Cancer

GENDER: Males

AGE GROUP: 18 and above

TRIAL STATUS: Completed

Cluster Headaches – ENFORCE STUDY

If you or someone you know has been diagnosed with cluster headaches, a clinical research study may be an option.   Wesley Medical Research are looking for people who are …

CONDITION: Neurological

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Recruiting

Kava in the treatment of Generalised Anxiety Disorder (KGAD)

An NHMRC funded clinical trial investigating the effects of a herbal medicine extract called Kava for individuals with Generalised Anxiety Disorder (GAD). The KGAD study is an 18-week, double blind, …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Completed

Psoriasis Clinical Trial

Researchers are trialling an investigational medication for the potential treatment of Plaque Psoriasis. By participating in this study you will help to obtain important information about whether this investigational medication …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 to 75 years

TRIAL STATUS: Closed: follow-up complete

N-acetylcysteine (NAC) in the treatment of Obsessive-Compulsive Disorder (OCD)

A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This study will determine if NAC is an effective treatment for …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 to 75 years

TRIAL STATUS: Completed

PARTICIPANTS NEEDED TO TAKE PART IN A FOOD SUPPLEMENT STUDY

ARE YOU: A pre-diabetic OR type 2 diabetic (diet-controlled or taking Metformin only) Aged between 18 and 70 years Someone with no significant weight change in the last 6 months …

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Recruiting

Dynavax Melanoma Trial

This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Completed

Male Pattern Hair Loss

Free trial of light therapy for hair loss Are you male? Have premature hair loss that is troubling you? Are you 18 to 60 years old? You are likely eligible …

CONDITION: Skin

GENDER: Males

AGE GROUP: 18 to 60 years

TRIAL STATUS: Recruiting

NAFLD (Non-alcoholic Fatty Liver Disease) Trial

What is the trial? Sponsor is developing the product RYI-018 as a potential treatment for non-alcoholic fatty liver disease (NAFLD), which is a very common disorder and refers to a …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 65 years

TRIAL STATUS: Recruiting

Facial Acne Medication Study

Adults and Children ages 9+ may qualify for a study of an investigational facial acne medication. To participate you must: Have at least 20 red irritated pimples and at least …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 9 and above

TRIAL STATUS: Completed

Do you have a peanut allergy?

Help us trial a medication which may help to protect people against severe reactions to peanuts. We’re looking for healthy people aged 18-65 with with a documented peanut allergy (of …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 to 65 years

TRIAL STATUS: Recruiting

Do you have Asthma?

Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 to 100 years

TRIAL STATUS: Completed

The ViKCoVaC Study

Are you aged between 50 and 80? Do you have Diabetes? You could play a role in the prevention of heart disease by participating in the ViKCoVaC study. Led by …

CONDITION: Cardiovascular

GENDER: Both males and females

AGE GROUP: 50 to 80 years

TRIAL STATUS: Recruiting

Dynavax Head and Neck Squamous Cell (HNSCC) Trial

This is a phase 2, open-label trial designed to evaluate the safety, tolerability, biologic activity, and preliminary efficacy of intratumoral SD 101 injections in combination with Keytruda (pembrolizumab) in patients …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

Chronic Pancreatitis Trial

Linear is currently inviting volunteers who have impaired function of their pancreas (a condition called exocrine pancreatic insufficiency, or EPI).  This condition is often caused by chronic pancreatitis, or where part …

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

The effects of video game playing on cognition, physical ability and sleep in older adults

The study is conducted in response to the need to maintain older adults’ daily functioning through stimulating environments despite the aging process. This study will involve older adults playing video games …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 40 and above

TRIAL STATUS: Recruiting

A Post-Marketing Safety Study to Evaluate the Occurrence of Aseptic Meningitis Syndrome (AMS) in an Adult Population Treated with Intragam® 10 NF

The purpose of this study is to collect data. The sponsor will be collecting medical information from study participants (through an interview and a phone call up to 7 days …

CONDITION: Blood

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Terminated

Weekend Study

20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 45 years

TRIAL STATUS: Completed

Probiotic Clinical Trial

Are you in Good Health? Are you aged 18 or over? Do you live in Sydney? You may qualify* to take part in a trial looking at the potential changes …

CONDITION: Oral and Gastrointestinal

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

COMPARE Aphasia Trial

What is COMPARE? COMPARE is an Australian national randomised controlled trial which aims to compare two types of intensive speech pathology treatments (Constraint Induced Aphasia Therapy; Multi-modality Aphasia Therapy) to …

CONDITION: Stroke

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

LE16072 Healthy Volunteer Trial

This is a phase I study assessing the safety and tolerability of single dose of a study drug which is being developed for the treatment of hyperuricemia and gout. Eligible …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 50 years

TRIAL STATUS: Closed: follow-up complete

LE16053 Healthy Volunteer Trial

This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke. …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 50 years

TRIAL STATUS: Closed: follow-up continuing

Stage III Non-Small Cell Lung Cancer

This study for patients with Stage III non-small cell lung cancer seeks to assess whether the addition of oral veliparib versus placebo to Paclitaxel/Carboplatin-based chemoradiotherapy with Paclitaxel/Carboplatin consolidation will improve …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Terminated

A Randomised Controlled Trial of Antivenom for Red-Bellied Black Snake Envenoming (RBBS)

The purpose of this project is to investigate the effectiveness and safety of early antivenom administration for the treatment of red-bellied black snake bites/envenoming. Red-bellied black snakebites (RBBS) are the …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

Mild to Moderate Knee Pain

Do you have a painful and stiff knee? Does it affect your ability to talk long distances, to walk up flights of stairs?  Is Your knee pain affecting your sleep …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP: 21 to 75 years

TRIAL STATUS: Recruiting

Randomised Controlled Trial of Early Antivenom Administration in Australian Snakebite [ESAA]

Snake bites are not common in Australia, but cause severe effects and often occur in rural and regional parts of Australia. Antivenoms exist for the treatment of many of these …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

LE16061 Healthy Volunteer Trial

A Phase 1, Single-Center, Open-label Study to Evaluate the Safety and Pharmacokinetics of Two Tablet Formulations of PRN1008. The purpose of this study is to investigate the relative bioavailability (the …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 65 years

TRIAL STATUS: Closed: follow-up complete

A Phase I/IIa Study of the Efficacy and Safety of ASN-002 in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma

Have you been diagnosed with or suspected to have a nodular Basal Cell Carcinoma (BCC)?   CLINICAL RESEARCH STUDY We are seeking volunteers with nodular BCC to participate in a …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

Atopic Dermatitis

This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed